申请人:Balzarini Maria Rene Jan
公开号:US20080076824A1
公开(公告)日:2008-03-27
The present invention relates to the discovery of a novel class of compounds that inhibit the replication of human immunodeficiency virus (HIV) and approaches to identify these compounds. More specifically, it has been found that enzymatically prepared alpha-hydroxyglycinamide and synthetically prepared alpha-hydroxyglycinamide inhibit the replication of HIV in human serum. Embodiments include methods to identify modified glycinamide compounds that inhibit HUV, methods to isolate and synthesize modified glycinamide compounds, and therapeutic compositions comprising these compounds.
本发明涉及一种新型化合物类别的发现,该类化合物能够抑制人类免疫缺陷病毒(HIV)的复制,并提供了鉴定这些化合物的方法。具体来说,发现经酶法制备的α-羟基甘氨酰胺和人工合成的α-羟基甘氨酰胺能够抑制HIV在人血清中的复制。实施例包括鉴定抑制HUV的改性甘氨酰胺化合物的方法,分离和合成改性甘氨酰胺化合物的方法,以及包含这些化合物的治疗组合物。